Clinical trial
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients…
NCT00233402 · Photocure, Industry · Completed
Key facts
| NCT number | NCT00233402 |
|---|---|
| Title | Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy |
| Official title | A Randomized, Comparative, Controlled Phase III, Multicenter Study of Hexvix Fluorescence Cystoscopy and White Light Cystoscopy in the Detection Of Papillary Bladder Cancer and the Early Recurrence Rate in Patients With Bladder Cancer |
| Lead sponsor | Photocure, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Hexvix, Standard white light cystoscopy |
| Enrollment | 789 |
| Start date | Jan 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Oct 5, 2005 |
| Last update posted | Oct 11, 2013 |
| Countries | Austria, Canada, Germany, Netherlands, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: